.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Fish and Richardson
Baxter
Healthtrust
Federal Trade Commission
UBS
Julphar
Cipla
AstraZeneca
McKinsey

Generated: December 13, 2017

DrugPatentWatch Database Preview

NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for naloxone hydrochloride; pentazocine hydrochloride and what is the scope of naloxone hydrochloride; pentazocine hydrochloride freedom to operate?

Naloxone hydrochloride; pentazocine hydrochloride
is the generic ingredient in two branded drugs marketed by Gavis Pharms, Sun Pharm Inds Ltd, Watson Labs, and Sanofi Aventis Us, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for naloxone hydrochloride; pentazocine hydrochloride. Eight suppliers are listed for this compound.

Summary for NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE

Pharmacology for NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds LtdNALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEnaloxone hydrochloride; pentazocine hydrochlorideTABLET;ORAL075523-001Mar 17, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsTALWIN NXnaloxone hydrochloride; pentazocine hydrochlorideTABLET;ORAL018733-001Dec 16, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsNALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEnaloxone hydrochloride; pentazocine hydrochlorideTABLET;ORAL074736-001Jan 21, 1997ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Gavis PharmsNALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEnaloxone hydrochloride; pentazocine hydrochlorideTABLET;ORAL075735-001Jul 11, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: naloxone hydrochloride; pentazocine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsTALWIN NXnaloxone hydrochloride; pentazocine hydrochlorideTABLET;ORAL018733-001Dec 16, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Healthtrust
Boehringer Ingelheim
Teva
US Department of Justice
Queensland Health
Medtronic
McKesson
Moodys
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot